Immunogenicity and Safety of Different Doses of Fluzone® Influenza

NCT00253734 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
217
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)